End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58,800 KRW | +2.44% | +0.51% | -18.33% |
03-28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
03-07 | SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline | CI |
Chart calendar SK bioscience Co.,Ltd.
Upcoming events on SK bioscience Co.,Ltd.
Past events on SK bioscience Co.,Ltd.
05/02/2024 | Investor Meeting |
04/02/2024 | Investor Meeting |
02/02/2024 01:00 | Investor Meeting |
01/02/2024 07:00 | Q4 2023 Earnings Call |
31/01/2024 | Q4 2023 Earnings Release |
31/10/2023 | Investor Meeting - Day - 6 |
30/10/2023 | Investor Meeting - Day - 5 |
29/10/2023 | Investor Meeting - Day - 4 |
28/10/2023 | Investor Meeting - Day - 3 |
27/10/2023 | Investor Meeting - Day - 2 |
27/10/2023 02:00 | Investor Meeting - Day - 1 |
26/10/2023 08:00 | Q3 2023 Earnings Call |
25/10/2023 | Q3 2023 Earnings Release |
31/07/2023 02:00 | Investor Meeting |
28/07/2023 08:30 | Q2 2023 Earnings Call |
27/07/2023 | Q2 2023 Earnings Release |
28/04/2023 02:00 | Q1 2023 Earnings Call |
27/04/2023 06:00 | Investor Meeting |
27/04/2023 06:00 | Analyst Meeting - NH Investment & Securities |
26/04/2023 | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 183 | 226 204 10.81% | 929 1 016 -8.55% | 457 512 -10.82% | 370 338 9.16% | 246 |
EBITDA Billions KRW | Released Forecast Spread | 0,00 | 0,00 0,00 - | 493 498 -0.93% | 142 198 -28.24% | 0,00 24,7 - | -8,62 |
EBIT Billions KRW | Released Forecast Spread | 0,00 | 37,7 25,4 48.47% | 474 482 -1.59% | 115 178 -35.31% | -12,0 -9,31 -28.82% | -68,6 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 | 0,00 0,00 - | 471 482 -2.16% | 142 183 -22.62% | 7,33 -6,90 206.18% | -38,4 |
Net income Billions KRW | Released Forecast Spread | 0,00 | 0,00 0,00 - | 355 385 -7.84% | 122 150 -18.46% | 22,3 10,2 119.59% | -38,7 |
EPS KRW | Released Forecast Spread | 6 933 | 0,00 0,00 - | 4 810 5 162 -6.82% | 1 590 1 958 -18.79% | 0,00 133 - | -504 |
Announcement Date | 30/03/20 | 23/03/21 | 07/02/22 | 08/02/23 | 01/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 257 | 451 554 -18.59% | 87,1 150 -41.83% | 138 140 -1.42% | 91,1 191 -52.4% | 140 191 -26.56% | 20,6 45,6 -54.8% | 26,5 25,8 2.76% | 232 131 77.17% | 90,6 65,7 37.85% | 46,6 | 54,2 | 89,0 | 67,0 |
EBITDA Billions KRW | Released Forecast Spread | 67,6 70,6 -4.21% | 16,6 45,8 -63.84% | -20,9 17,3 -220.92% | |||||||||||
EBIT Billions KRW | Released Forecast Spread | 254 263 -3.4% | 23,8 64,3 -63.04% | 61,2 60,4 1.33% | 21,4 85,5 -75.01% | 8,71 70,3 -87.6% | -29,2 6,80 -529.25% | -35,3 -26,4 -33.58% | 60,9 5,23 1064.4% | -8,43 -6,58 -28.17% | -18,6 | -18,4 | -1,25 | -6,40 | |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 252 257 -2.15% | 32,8 29,9 9.68% | 55,3 63,3 -12.53% | 23,2 58,7 -60.49% | 30,5 66,6 -54.25% | -25,7 4,75 -640.32% | -29,2 -22,4 -30.4% | 58,6 9,43 521.45% | 3,61 -16,9 121.33% | -17,3 | -18,4 | -1,00 | -4,70 | |
Net income Billions KRW | Released Forecast Spread | 184 217 -15.11% | 27,8 20,0 39.03% | 46,1 47,6 -3.06% | 20,8 59,7 -65.22% | 27,7 49,6 -44.03% | -14,3 4,73 -401.44% | -16,0 -20,6 22.51% | 48,4 -21,7 323% | 4,17 -14,0 129.86% | -13,2 | -14,0 | -0,70 | -3,60 | |
EPS KRW | Released Forecast Spread | 1 342 | |||||||||||||
Announcement Date | 12/08/21 | 07/02/22 | 29/04/22 | 29/07/22 | 31/10/22 | 08/02/23 | 27/04/23 | 28/07/23 | 26/10/23 | 01/02/24 | - | - | - | - |
Today 12:00 | INCYTE CORPORATION: Q1 2024 Earnings Release |
01/05/2024 | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
01/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
06/05/2024 12:00 | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
06/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
06/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
06/05/2024 | REVANCE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
06/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
07/05/2024 07:00 | BIOGAIA AB: Q1 2024 Earnings Release |
Past sector events for SK bioscience Co.,Ltd.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A302440 Stock
- Calendar SK bioscience Co.,Ltd.